The use of Caralluma fimbriata as an appetite suppressant and weight loss supplement: a systematic review and meta-analysis of clinical trials.

Ranil Jayawardena Tormalli V Francis Sachith Abhayaratna Priyanga Ranasinghe

Published in: BMC complementary medicine and therapies (2021)

Appetite parameters showed no significant changes and metabolic parameters did not improve with C.fimbriata supplementation therefore it is unlikely to recommend C. fimbriata as a weight loss supplement and an appetite suppressant.

Keyphrases

weight loss
bariatric surgery
roux en y gastric bypass
clinical trial
gastric bypass
glycemic control
weight gain
randomized controlled trial
adipose tissue
study protocol
body weight